Family Filter: On Subscribe

Search Results - pharmaceuticals

1-10 of about 21 advanced search
Penam Pharmaceuticals Pvt. Ltd.
Penam Pharmaceuticals Pvt. Ltd.
  • 5 months ago
  • 66
  • 0
  • 0

Penam is an ISO 9001:2000 & GMP certified company.Penam is a upcoming specialty pharmaceutical company with a balanced portfolio of branded and generic products, We pursue a multi-layered growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses. We offer beta & non-beta lactum range of products.For more details log on to http://www.penampharma.com

Genre: How-to

by: raviashok54

Penam Pharmaceuticals Pvt. Ltd. - Penning Good Health
Penam Pharmaceuticals Pvt. Ltd. - Penning Good Health
  • 5 months ago
  • 90
  • 0
  • 0

Penam is an ISO 9001:2000 & GMP certified company.Penam is a upcoming specialty pharmaceutical company with a balanced portfolio of branded and generic products, We pursue a multi-layered growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses. We offer beta & non-beta lactum range of products..For more details log on to http://www.penampharma.com

Genre: Funny Videos

by: Deepam

Xenerex Pharmaceuticals
Xenerex Pharmaceuticals
  • 5 days ago
  • 4
  • 0
  • 0

http-//www.ZenerxMan.com All-Natural Herbal Formula combines 2,500 years of wisdom with modern medicine to create the ultimate male enhancement and virility potion

Genre: Funny Videos

by: alexmason

Learn about Viagra - Pharmaceuticals
Learn about Viagra - Pharmaceuticals
  • 6 months ago
  • 327
  • 0
  • 0

Viagra Facts -Learn about the prescription drug Viagra in this video, where a pharmacist explains how Viagra treats erectile dysfunction.

Genre: News Videos

by: health24

Raptor Pharmaceuticals Provides Update on Targeting Platforms
Raptor Pharmaceuticals Provides Update on Targeting Platforms
  • 8 months ago
  • 51
  • 0
  • 0

Enters Collaboration on Receptor Associated Protein (RAP) Supports NeuroTrans(TM) Platform with Japanese Patent NOVATO, Calif., March 6 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced updates on its preclinical program which utilizes drug-targeting platforms derived from the human receptor-associated protein ("RAP") and related proteins. The Company signed a collaborative research agreement with the Brigham and Women's Hospital involving the characterization of certain modified RAP proteins. At the Hospital, this research will be conducted in the laboratory of Dr. Stephen Blacklow. The Company has also announced today a patent issuance in Japan relating to the NeuroTrans(TM) program.

Genre: News Videos

by: comments

Need a great sex ? Learn about Levitra - Pharmaceuticals
Need a great sex ? Learn about Levitra - Pharmaceuticals
  • 6 months ago
  • 293
  • 0
  • 0

Levitra description .Learn about the prescription drug Levitra in this video, where a pharmacist explains how Levitra treats erectile dysfunction.

Genre: Animation

by: health24

Need a great sex ? Learn about Female Viagra - Pharmaceuticals
Need a great sex ? Learn about Female Viagra - Pharmaceuticals
  • 6 months ago
  • 544
  • 0
  • 0

Female Viagra represents a serious approach to the problem of female sexual arousal disorder (FSAD) and female sexual dysfunction (FSD), formulated scientifically to provide satisfaction in terms of sexual needs and lasting pleasure.

Genre: Animation

by: health24

Provectus Trials Show Promise
Provectus Trials Show Promise
  • 3 months ago
  • 24
  • 0
  • 0

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT) reports on its year-to-date clinical and corporate accomplishments in a letter to shareholders from Craig Dees, Ph.D., CEO of Provectus.To view Multimedia News Release, go to http://www.prnewswire.com/mnr/pvct/39628/

Genre: News Videos

by: comments

PROVECTUS PV-10 INTERIM PHASE 2 SAFETY AND EFFICACY RESULTS ...
PROVECTUS PV-10 INTERIM PHASE 2 SAFETY AND EFFICACY RESULTS ...
  • 8 months ago
  • 114
  • 0
  • 0

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced that the interim safety and efficacy results from the first 20 subjects in its Phase 2 clinical trial for the treatment of metastatic melanoma are as good as or better than Phase 1 data. Additionally, extended Phase 1 survival data was reported. To view Multimedia News Release go to http://www.prnewswire.com/mnr/pvct/37429/

Genre: News Videos

by: comments

PV-10 Effective Against Melanoma
PV-10 Effective Against Melanoma
  • 6 months ago
  • 136
  • 0
  • 0

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has announced interim data from the first 40 subjects in its Phase 2 clinical trial for the treatment of metastatic melanoma. PV-10 treatment was well tolerated and caused selective tumor destruction in the majority of subjects. Additional data on untreated tumors corroborated observations of a possible bystander effect seen during earlier Phase 1 testing. These data were presented today at the American Society of Clinical Oncology 2009 Annual Meeting, Abstract #9060, entitled “Chemoablation of melanoma with intralesional rose bengal (PV-10), in the General Poster Session.To view Multimedia News Release, go to http://www.prnewswire.com/mnr/pvct/37868/

Genre: News Videos

by: comments

Pg 1 of 3
12 3  Next > 

Other Videos From The Web

YOU WANT CHAN...
YOU WANT CHANGE! THEN BRING THE VOICE TO THEIR DOORSTEP AND FAM
the pharmaceutical industry and do...